Provided by Tiger Trade Technology Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.09
-0.0450-3.98%
Volume:48.25K
Turnover:53.75K
Market Cap:3.82M
PE:-0.17
High:1.16
Open:1.13
Low:1.04
Close:1.13
52wk High:8.62
52wk Low:1.02
Shares:3.52M
Float Shares:1.77M
Volume Ratio:1.27
T/O Rate:2.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.3166
EPS(LYR):-11.7369
ROE:-332.85%
ROA:-127.13%
PB:-0.55
PE(LYR):-0.09

Loading ...

60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement With Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement

THOMSON REUTERS
·
Jun 11

60 Degrees Pharmaceuticals announces annual shareholder meeting

Reuters
·
Jun 09

Honeywell's Quantinuum Valued at $17.6 Billion as Shares Rise in Nasdaq Debut

Reuters
·
Jun 05

60 Degrees details tafenoquine priority review voucher strategy

TIPRANKS
·
Jun 04

60 Degrees Pharmaceuticals - May Submit Nda for Tafenoquine to FDA Before End of Q1 2028 - SEC Filing

THOMSON REUTERS
·
Jun 04

60 Degrees announces early enrollment of first patient in trial of tafenoquine

TIPRANKS
·
May 26

60 Degrees Pharma enrolls first patient in tafenoquine babesiosis trial in US Northeast hospitals

Reuters
·
May 26

60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized With Babesiosis

THOMSON REUTERS
·
May 26

60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
May 22

U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, Nvidia

Reuters
·
May 21

60 Degrees Pharmaceuticals Inc : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
May 21

60 Degrees Pharm Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
May 21

60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
May 20

60 Degrees Pharma director Eric Francois files initial beneficial ownership statement

Reuters
·
May 20

60 Degrees Pharma appoints Eric Francois to board

Reuters
·
May 19

60 Degrees Q1 EPS $(1.28) Misses $(0.76) Estimate, Sales $76.377K Miss $435.000K Estimate

Benzinga Earnings
·
May 15

60 Degrees Pharmaceuticals Q1 Operating Expenses USD 2.17 Million

THOMSON REUTERS
·
May 15

60 Degrees Pharmaceuticals Q1 Net Income USD -2.21 Million

THOMSON REUTERS
·
May 15

Press Release: 60 Degrees Pharmaceuticals Announces First Quarter 2026 Results

Dow Jones
·
May 15

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results

GlobeNewswire
·
May 15